Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 10;43(32):3439-3445.
doi: 10.1200/JCO-25-01817. Epub 2025 Sep 26.

Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era

Affiliations

Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era

Tafadzwa L Chaunzwa et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Axial MRI slice showing the hippocampus (contoured in yellow) and the hippocampal avoidance region (5 mm margin expansion in purple). The prescription dose was 25 Gy in 10 daily fractions.
Figure 2:
Figure 2:
Axial and sagittal post-contrast T1-weighted MRI demonstrating a left anterior hippocampal metastasis.
Figure 3:
Figure 3:
Stereotactic radiosurgery plan targeting hippocampal brain metastasis with conformal dose distribution.

References

    1. Gondi Vinai, Pugh Stephanie L., Mehta Minesh P., Wefel Jeffrey S., Tomé Wolfgang A., Sun Alexander Y., Grecula John, Redmond Kristin J., Fogh Shannon, Gaspar Laurie, Konski Andre, Bovi Joseph, Robinson Clifford G, Corn Benjamin, Videtic Gregory M., Lok Benjamin H., Yoon Harold A., Heinzerling John H., DeNittis Albert S., McGarry Ronald C., Devisetty Kiran, Kundapur Vijayananda, Wu Abraham J., McCarron Edward C, Thibault Isabelle, Simon Edmond L, Baschnagel Andrew M, Narayan Samir, Pollock Jondavid, Paulus Rebecca, Kachnic Lisa A., for the NRG Oncology. Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients with SmallCell Lung Cancer: Randomized Phase II/III Trial NRG-CC003. J. Clin. Oncol - PMC - PubMed
    1. Aupérin A et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. The New England journal of medicine 341, (1999). - PubMed
    1. Takahashi T et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. The Lancet. Oncology 18, (2017). - PubMed
    1. Cheng Y et al. Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer. The New England journal of medicine 391, (2024). - PubMed
    1. Gondi V et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys 86, 656–664 (2013). - PMC - PubMed

LinkOut - more resources